𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effect of differences in cancer cells and tumor growth sites on recruiting bone marrow-derived endothelial cells and myofibroblasts in cancer-induced stroma

✍ Scribed by Takafumi Sangai; Genichiro Ishii; Keiji Kodama; Shin'ichi Miyamoto; Yasuyuki Aoyagi; Takashi Ito; Junji Magae; Hiroki Sasaki; Takeshi Nagashima; Masaru Miyazaki; Atsushi Ochiai


Publisher
John Wiley and Sons
Year
2005
Tongue
French
Weight
619 KB
Volume
115
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Cancer‐stromal interaction is well known to play important roles during cancer progression. Recently we have demonstrated that bone marrow‐derived vascular endothelial cells (BMD‐VE) and myofibroblasts (BMD‐MF) are recruited into the human pancreatic cancer cell line Capan‐1 induced stroma. To assess the effect of the difference in cancer cell types on the recruitment of BMD‐VE and BMD‐MF, 10 kinds of human cancer cell line were implanted into the subctaneous tissue of the immunodeficient mice transplanted with bone marrow of double‐mutant mice (RAG‐1−/− β‐gal Tg or RAG‐1−/− GFP Tg). The recruitment frequency of BMD‐VE (%BMD‐VE) and BMD‐MF (%BMD‐MF), and tumor‐associated parameters [tumor volume (TV), microvessel density (MVD) and stromal proportion (%St)] were measured. The correlation among them was analyzed. Although %BMD‐VE and %BMD‐MF varied (from 0 to 21.6%, 0 to 29.6%, respectively), depending on the cancer cell line, both parameters were significantly correlated with %St (p < 0.005). Furthermore %BMD‐VE and %BMD‐MF also significantly correlated (p < 0.005). In order to assess the effect of tumor growth sites on the recruitment of the cells of interest, a human pancreatic cancer cell line, Capan‐1, was transplanted into 5 different sites: subcutaneous tissue, peritoneum, liver, spleen and lung. Tumors in the subcutaneous tissue and peritoneum induced desmoplastic stroma (%St = 22.7%, 19.5%, respectively) and contained BMD‐VE (%BMD‐VE = 21.6%, 16.5% respectively) and BMD‐MF (%BMD‐MF = 29.6%, 24.5%, respectively), but weak stromal induction without recruitment of BMD‐VE or ‐MF was observed in the tumors at of the liver, spleen and lung (%St = 9.7%, 9.1%, 5.4%, respectively). cDNA microarray analysis identified the 29 genes that expression was especially up‐ or down‐regulated in the cell line that induced an abundant stromal reaction. However they did not encoded the molecules that were directly involved in stromal cell recruitment (chemokines), differentiation (cytokines) or proliferation (growth factors). These results indicate that the recruitment of BMD‐VE and ‐MF is required for stromal formation during cancer progression and that the cancer microenvironment is important in stromal reaction and the recruitment of BMD‐VE and ‐MF. © 2005 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Potent effect of 5-HPBR, a butanoate der
✍ Hye-Sook Han; Youn-Ja Kwon; Si-Ho Park; Eun-Joo Kim; Young-Soy Rho; Hong-Sig Sin 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 363 KB 👁 1 views

Fenretinide, 4-(N-hydroxyphenyl) retinamide (4-HPR), has demonstrated anticancer activity associated with a favorable toxicity profile and is now being investigated in several clinical trials. However, its plasma levels in patients have been far lower than the effective concentration required to ind

Impact of platinum-based chemotherapy on
✍ Pauline Wimberger; Carina Roth; Klaus Pantel; Sabine Kasimir-Bauer; Rainer Kimmi 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 298 KB 👁 1 views

## Abstract There is an unmet need for biomarkers for the prediction and monitoring of anticancer therapies. Here, we measured the concentrations of nucleosomes and DNA, protease and caspase activities in serum of 62 patients with ovarian cancer before and after first‐line carboplatin/taxane‐based

Growth-inhibitory effect of tamoxifen an
✍ Gabriella Ferrandina; Giovanni Almadori; Nicola Maggiano; Paola Lanza; Cristiano 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 412 KB 👁 1 views

Quercetin and tamoxifen, in a range of concentrations between 0.01 and 5 M, exert a dose-dependent inhibition on the anchorage-dependent and anchorage-independent cell growth of Hep2 and CO-K3 laryngeal cancer cell lines. Cell cycle analysis revealed that the growth-inhibitory effect was associated